Direct Marketing Expert in Pharmaceutical Marketing

A direct marketing expert in retail pharmacy practices and HIPAA regulations was needed for a class action suit against a national pharmacy chain. The plaintiff alleged that the drug store chain was placing customers’ valuable proprietary information, obtained via prescriptions, into a marketing database for the purpose of its direct marketing efforts. The plaintiff was also seeking damages against pharmaceutical company sponsors who pay the retail pharmacy chain to implement the direct marketing program in an effort to sell more of its drug, based on customer information available through the pharmacy's database.

IMS ExpertServices™ sought a direct to consumer marketing expert with experience in pharmaceutical marketing efforts. Specifically, the client requested an expert familiar with the direct mail and telemarketing efforts relating to the medication support programs used by the pharmacy and pharmaceutical industries.

More Info...

Pharmaceutical Marketing Strategy Expert

This expert in direct marketing, located by IMS Expert Services, has more than 20 years of experience in healthcare, pharmaceutical marketing, and the law. He holds both a J.D. and Ph.D., and is currently a Professor of Pharmaceutical Strategy and Marketing. He is a frequent speaker on topics of pharmaceutical marketing, promotion and advertising. He has published more than 100 articles in academic journals and conference proceedings. This expert has extensive experience as a litigation consultant and has worked on several high-profile cases. IMS Reference #3217044

Pharmaceutical Industry Expert

This direct marketing expert has a long and impressive career in the pharmaceutical industry and biotechnology consulting industry. He developed extensive marketing experience domestically and internationally and is familiar with the various marketing arrangements between pharmacies and pharmaceutical companies. At one point in his career he established a direct to consumer advertising department for a major pharmaceutical manufacturer. IMS Reference #5011991